N6,N6-Dimethyladenosine - HY-101984
Nur noch %1 verfügbar
Catalog #
HY-101984
Ab
26,00 €
N6,N6-Dimethyladenosine, a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6,N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein ADAM17. N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-101984/N6-N6-Dimethyladenosine-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Neuroscience-Neuromodulation |
| CAS | 2620-62-4 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 295.29 |
| Solubility | DMSO : ≥ 125 mg/mL |
| Clinical Information | No Development Reported |
| Target | Adenosine Receptor;Akt;Nucleoside Antimetabolite/Analog;SARS-CoV |
| Application: | Neuroscience-Neuromodulation |
|---|